H
Hikal
Partnering with pharmaceuticals and agrochemicals to deliver active ingredients, intermediates, and custom R&D services
About Hikal
Hikal Limited, established in 1988, operates in the pharmaceuticals, life sciences, biotechnology, agrochemicals, and specialty chemicals sectors. The company specializes in providing active pharmaceutical ingredients (APIs), intermediates, and contract development and manufacturing services. Hikal serves a diverse clientele, including global pharmaceutical and crop protection companies, by offering custom manufacturing solutions tailored to their specific needs. The business model revolves around long-term partnerships with clients, focusing on delivering high-quality, sustainable, and innovative solutions. Hikal generates revenue through the sale of APIs, intermediates, and R&D services, leveraging its robust capabilities in research and technology to meet the evolving demands of its clients. The company is committed to inclusive and sustainable growth, ensuring that its operations benefit both its stakeholders and the environment.
Source: Dealroom company dataAt a glance
- Founded
- 1988
- Headquarters
- Navi Mumbai, India
- Sector
- Health
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Hikal on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Hikal on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.